The LeAAPS trial is evaluating if LAAE can prevent strokes in high-risk cardiac surgery patients without a history of Afib. The results from this trial could expand current guidelines across the U.S and advance patient care.
Discover more: <a href="https://t.co/W9PV0ZG1Qv" target="_blank">https://t.co/W9PV0ZG1Qv</a>… <a href="https://t.co/pNh0SURFum" target="_blank">https://t.co/pNh0SURFum</a>